US$ 20.03
semaglutide and vision loss VA Clinicians Should Counsel Initiators About a 2-Fold Greater Risk of From 'Eye Stroke' Long Island patient lost vision
Description
Some research suggests discontinuation rates for GLP-1s may be significantly higher in the real world, particularly in people with obesity
In one clinical trial funded by Eli Lilly, participants who took Tirzepatide 5.0 mg lost 16.1 kg of body weight, participants who took Tirzepatide 10 mg lost 22.2 kg of body weight, and participants who took Tirzepatide 15 mg lost 23.6 kg of body weight, while only 2.4 kg weight loss was observed in participants taking placebo
It does not include personalized follow-up care, dosage monitoring, or nutrition and fitness support
What Happens Between Semaglutide Injections

Some people notice changes within a few days, such as reduced appetite or feeling full more quickly
